Jie Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Topics

Squamous Cell Carcinoma

Tyrosine Kinase

Liver Metastases

Top Venues

Thoracic cancer

Nature communications

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy. Nature communications 15 (1) (2024)
Chao Wang, Kailun Fei, Lihui Liu, Jianchun Daun, Zhijie Wang, Sini Li, Jiachen Xu, Xue Zhang, Yanhua Tian, Yan Qu, Hua Bai, Jie Wang
Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment. Thoracic cancer (2023)
Boyang Sun, Tian Qiu, Xiaoling Zeng, Jianchun Duan, Hua Bai, Jiachen Xu, Jin Li, Jun-Ling Li, Xuezhi Hao, Yutao Liu, Lin Lin, Hongyu Wang, Xin Zhang, Jia Zhong, Jie Wang, Jianming Ying, Zhijie Wang
Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors. Cancer research communications 3 (4) (2023)
Roy S Herbst, Yi-Long Wu, Thomas John, Christian Grohe, Margarita Majem, Jie Wang, Terufumi Kato, Jonathan Wade Goldman, Konstantin Laktionov, Sang-We Kim, Chong-Jen Yu, Huu Vinh Vu, Shun Lu, Kye Young Lee, Guzel Mukhametshina, Charuwan Akewanlop, Filippo de Marinis, Laura Bonanno, Manuel Dómine, Frances A Shepherd, Damien Urban, Xiangning Huang, Ana Bolanos, Marta Stachowiak, Masahiro Tsuboi
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sini Li, Yan Qu, Lihui Liu, Chao Wang, Li Yuan, Hua Bai, Jie Wang
Tumour-derived exosomes in liver metastasis: A Pandora's box. Cell proliferation (2023)
Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qi-Ming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, An-Wen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Li-Yun Miao, Zhihong Zhang, Hui Zhao, Jun Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Shi Jin, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yang Du, Ye Liu, Di Wang, Hua Bai, Zhijie Wang, Xiran He, Pei Zhang, Zhenyu Zhang, Jie Wang
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumors. Journal for immunotherapy of cancer 10 (2) (2022)
Jun Zhao, Hua Bai, Xin Wang, Yuyan Wang, Jianchun Duan, Hanxiao Chen, Zhiyi Xue, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Yi-Long Wu, Jie Wang
Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFR m+ non-small-cell lung cancer. Future oncology (London, England) 18 (12) (2022)
Geyun Chang, Weihua Li, Hua Bai, Jianchun Daun, Zhijie Wang, Xinyang Du, Ruofei Yu, Yaxi Wang, Minghao Wang, Yi-Xiang Zhu, Xue Zhang, Li Li, Rui Wan, Jie Wang
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 13 (21) (2022)
Xinyang Du, Hua Bai, Zhijie Wang, Jianchun Daun, Zheng Liu, Jiachen Xu, Geyun Chang, Yi-Xiang Zhu, Jie Wang
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs. Thoracic cancer 13 (9) (2022)
Ying Liu, Ying Cheng, Qiming Wang, Kai Li, Jianhua Shi, Lin Wu, Baohui Han, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaoling Li
Effectiveness of anlotinib in patients with small-cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study. Thoracic cancer 12 (22) (2021)
Shuluan Li, Pei Zhang, Tianyu Wang, Jie Wang, Jianchun Duan
Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report. Thoracic cancer 12 (23) (2021)
Hua Bai, Jianchun Duan, Chengcheng Li, Wenzhuan Xie, Wenfeng Fang, Yu Xu, Guoqiang Wang, Rui Wan, Jing Sun, Jiachen Xu, Xin Wang, Kailun Fei, Zhengyi Zhao, Shangli Cai, Li Zhang, Jie Wang, Zhijie Wang
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma. Journal for immunotherapy of cancer 8 (2) (2021)
Jun Du, Yundi Zhang, Yiting Dong, Jianchun Daun, Hua Bai, Jie Wang, Jiachen Xu, Zhijie Wang
Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer. Thoracic cancer 12 (20) (2021)
Lin Shen, Jun Guo, Qingyuan Zhang, Hongming Pan, Ying Yuan, Yuxian Bai, Tianshu Liu, Qing Zhou, Jun Zhao, Yongqian Shu, Xiaoming Huang, Siyang Wang, Jie Wang, Aiping Zhou, Dingwei Ye, Ting Sun, Yujuan Gao, Silu Yang, Zoubai Wang, Jian Li, Yi-Long Wu
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study. Journal for immunotherapy of cancer 8 (1) (2021)
Yufan Yang, Tao Zhang, Zongmei Zhou, Jun Liang, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lv, Lei Deng, Xin Wang, Wenqing Wang, Jianyang Wang, Wenyang Liu, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thoracic cancer 13 (3) (2021)
Ying Cheng, Qiming Wang, Kai Li, Jianhua Shi, Lin Wu, Baohui Han, Gongyan Chen, Jian-Xing He, Jie Wang, Haifeng Qin, Xiaoling Li
Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial. Cancer medicine 11 (4) (2021)
Kunpeng Xu, Jun Liang, Tao Zhang, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lu, Xin Wang, Lei Deng, Wenyang Liu, Jianyang Wang, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer. Thoracic cancer 12 (6) (2021)
Jiefei Han, Ruofei Yu, Jianchun Duan, Jin Li, Wei Zhao, Guoshuang Feng, Hua Bai, Yu-Qi Wang, Xue Zhang, Rui Wan, Jiachen Xu, Xin Wang, Yanfang Guan, Xuefeng Xia, Zhuoran Yao, Kailun Fei, David P Carbone, Zhijie Wang, Jie Wang
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers. Science advances 7 (21) (2021)
Xiran He, Yang Du, Zhijie Wang, Xin Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Pei Zhang, Di Wang, Yanhua Tian, Jiefei Han, Kailun Fei, Hua Bai, Jie Tian, Jie Wang
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma. Journal for immunotherapy of cancer 8 (2) (2021)
Bin Xu, Ke-Han Song, Yi Yao, Xiao-Rong Dong, Lin-Jun Li, Qun Wang, Ji-Yuan Yang, Wei-Dong Hu, Zhi-Bin Xie, Zhi-Guo Luo, Xiu-Li Luo, Jing Liu, Zhi-Guo Rao, Hui-Bo Zhang, Jie Wu, Lan Li, Hong-Yun Gong, Qian Chu, Qi-Bin Song, Jie Wang
Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study. Cancer science 112 (6) (2021)
Lin Lin, Jing Sun, Jie Wang
Lung cancer and intraocular metastasis in gestation: Clinical experiences of a rare case. Thoracic cancer 11 (9) (2020)
Tao Zhang, Kunpeng Xu, Nan Bi, Li Zhang, Wei Jiang, Jun Liang, Lei Deng, Xin Wang, Jianyang Wang, Jie Wang, Luhua Wang
Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non-small cell lung cancer: Chinese multicenter report and literature review. Thoracic cancer 11 (10) (2020)
Kehan Song, Hongyun Gong, Bin Xu, Xiaorong Dong, Linjun Li, Wei-Dong Hu, Qun Wang, Zhibin Xie, Zhiguo Rao, Zhiguo Luo, Qian Chu, Feng Li, Jie Wang
Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter study. Cancer 127 (3) (2020)
Pei Zhang, Jianchun Duan, Hua Bai, Zhijie Wang, Shugeng Gao, Fengwei Tan, Yushun Gao, Xin Wang, Rui Wan, Jiachen Xu, Xiran He, Xiaoshuang Feng, Ruofei Yu, Jing Sun, Zhe Zhao, Kailun Fei, Ni Li, Jie He, Jie Wang
Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer. Thoracic cancer 12 (1) (2020)
Zhe Zhao, Hua Bai, Jianchun Duan, Jie Wang
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. Thoracic cancer 11 (6) (2020)
Zhe Zhao, Kailun Fei, Hua Bai, Zhijie Wang, Jianchun Duan, Jie Wang
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer. Thoracic cancer 12 (1) (2020)
Ruofei Yu, Hua Bai, Bingyu Gao, Tangai Li, Xiran He, Pei Zhang, Jie Wang
Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K/AKT apoptosis-inhibiting pathway. Thoracic cancer 12 (1) (2020)
Liangliang Cai, Hua Bai, Jianchun Duan, Zhijie Wang, Shugeng Gao, Di Wang, Shuhang Wang, Jun Jiang, Jiefei Han, Yanhua Tian, Xue Zhang, Hao Ye, Minghui Li, Bingding Huang, Jie He, Jie Wang
Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer. Journal for immunotherapy of cancer 7 (1) (2019)